Michael Forbes, CEO of Adastra, stated in his First push release: “Hurt reduction is often a critically significant and mainstream subject, and we're staying with the forefront of drug laws over the board.”“We'll Appraise how the commercialization of the substance fits in with our small business model at Adastra in an effort to placement ours